Grifols SA (GRFS)
9.35
+0.15
(+1.63%)
USD |
NASDAQ |
Dec 31, 16:00
9.345
0.00 (0.00%)
Pre-Market: 20:00
Grifols Total Assets (Quarterly): 23.33B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Ascendis Pharma A/S | 1.357B |
| NuCana Plc | 43.50M |
| Autolus Therapeutics Plc | 661.95M |
| Mereo BioPharma Group Plc | 53.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.46B |
| Shareholders Equity (Quarterly) | 6.085B |
| Debt to Equity Ratio | 1.871 |
| Current Ratio | 2.482 |
| Net Debt Paydown Yield | 0.06% |